Vascu- Guard Patch Lawsuits Being Investigated By Bernstein Liebhard LLP, Following Recent Recall and Reports of Severe Bleeding. NEW YORK, Sept. The Firm's investigation was prompted by Baxter's decision to recall several lots of the Vascu- Guard Patch product. CEA) surgery. Food& Drug Administration (FDA), some of these incidents required additional clinical intervention. Three patient deaths may also be linked to the Vascu- Guard Patch recall. The agency has classified this action as a Class II recall, which indicates that the affected Vascu- Guard Patches might cause a temporary health problem, or pose a slight threat of a serious nature or death. We urge anyone who experienced severe bleeding, blood clots or other complications following surgery with this device to contact our office as soon as possible, to ensure that their legal rights are protected. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The device is constructed from bovine pericardium sourced from U. S. In May 2. 01. 5, a Class I recall. Vascu- Guard Patch, following reports that customers were having difficulty distinguishing the smooth from rough surface of the patch as described in the labeled instructions for use. Incorrect orientation of the patch with the rough side toward the bloodstream can increase the risk of blood clots and embolism, placing patients at risk for serious complications including reduced blood flow, stroke, organ failure, or death. According to the FDA, Baxter reported 5. A Class I recall is the agency's most serious type of recall, and indicates that there is a reasonable probability that use of these products will cause serious adverse health consequences or death. VASCU-GUARD,Bovine Pericardium Patch 0.8 x 8cm for carotid patching,profundaplasty and vascular reconstruction (Apex processing). The US Food and Drug Administration (FDA) is spreading the word that the Vascu-Guard Peripheral Vascular Patch, a device designed to prevent bleeding after carotid. Prospective Randomized Trial Acuseal Vs. Vascu-guard Patching For Carotid Endarterectomy Patrick A. Stone, MD, Ali AbuRahma, Stephen Hass, David Phang, Albeir Mousa. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.
Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's . This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 1. East 4. 0th Street, New York, New York 1. Prior results do not guarantee or predict a similar outcome with respect to any future matter. All rights reserved.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
September 2016
Categories |